Home > Insider Trading > Filing (0001628280-20-011379)

Filing Details

Accession Number:: 0001628280-20-011379
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2020-07-31 18:16:24
Reporting Period:: 2020-03-24

Accepted Time:: 2020-07-31 18:16:24
Original Submission Date:: 2020-03-24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
727207	Accelerate Diagnostics Inc	AXDX	Laboratory Analytical Instruments (3826)	841072256

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1021413	John Patience	C/O Accelerate Diagnostics, Inc. 3950 S. Country Club Road, Suite 470 Tucson AZ 85714		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-03-24	5,000	$6.83	4,300,481	No	4	P	Indirect	By John Patience Living Trust dated 7/23/1993

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By John Patience Living Trust dated 7/23/1993

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	39,411	Indirect	By IRA
Common Stock	2,140,462	Indirect	By Patience Enterprises LP

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.81 to $6.85, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
Due to a clerical error, the reported shares owned indirectly by the reporting person through the John Patience Living Trust dated 7/23/1993 (the "Trust") has been adjusted to correct an understatement of 104,270 shares. The 104,270 shares represent (i) 59,600 shares acquired by the Trust on May 2, 2014, which were previously reported in the reporting person's Form 4 filed May 2, 2014 and inadvertently omitted in subsequent filings; (ii) 20,000 shares acquired by the Trust on December 1, 2016, which were incorrectly reported as acquired directly by the reporting person in the reporting person's Form 4 filed December 7, 2016 and in subsequent filings; and (iii) 24,670 shares acquired by the Trust on December 13, 2016, which were incorrectly reported as acquired directly by the reporting person in the reporting person's Form 4 filed December 14, 2016 and in subsequent filings.
These shares were previously reported as owned indirectly by the reporting person through the John Patience Defined Benefit Pension Plan but are now owned indirectly by the reporting person in the reporting person's individual retirement account (IRA).
Due to a clerical error, the reported shares owned indirectly by the reporting person through Patience Enterprises LP (the "Partnership") has been adjusted to correct an understatement of 29,800 shares. The 29,800 shares were acquired by the Partnership on May 2, 2014, which were previously reported in the reporting person's Form 4 filed May 2, 2014 and inadvertently omitted in subsequent filings.
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.